rucaparib,abiraterone,enzalutamide
astellas,pfizer,clovis oncology
['gu ', 'rucaparib', 'pcsm', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'triton3']
rucaparib improves rpfs when compared with physician s choice of therapy in patients with metastatic castration-resistant prostate cancer, according to results from the triton3 trial. presented at asco gu 2023. #gu23 #pcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.